"Protecting Infants: COVID-19 Vaccination During Pregnancy"
A study from the National Institute of Allergy and Infectious Diseases (NIAID) reveals that receiving an mRNA-based COVID-19 vaccination or booster during pregnancy provides infants with strong protection against symptomatic COVID-19 infection for at least six months after birth. The study, published in Pediatrics, emphasizes the importance of maternal vaccination to ensure infants are born with lasting protection until they are old enough to be vaccinated themselves. Infants born to mothers who received a COVID-19 vaccine and booster during pregnancy showed higher levels of antibodies at birth and greater protection from COVID-19 infection during their first six months, highlighting the significant benefits of maternal vaccination for newborns.